Clinical trials
Trials in Chile with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
223 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 10 |
| 2012 | 7 |
| 2013 | 9 |
| 2014 | 10 |
| 2015 | 13 |
| 2016 | 14 |
| 2017 | 12 |
| 2018 | 14 |
| 2019 | 13 |
| 2020 | 15 |
| 2021 | 27 |
| 2022 | 19 |
| 2023 | 23 |
| 2024 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 223 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pontificia Universidad Catolica de Chile | 58 |
| University of Chile | 40 |
| Universidad de los Andes, Chile | 13 |
| Universidad de Valparaiso | 10 |
| Universidad del Desarrollo | 6 |
| Universidad de La Frontera | 5 |
| Corporación de Rehabilitación Club de Leones Cruz del Sur | 3 |
| Fundacion Arturo Lopez Perez | 2 |
| Fundación San Carlos de Maipo | 2 |
| Hospital del Trabajador de Santiago | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 12 |
| Obesity | 9 |
| Breast Neoplasms | 5 |
| Cognitive Dysfunction | 5 |
| Critical Illness | 5 |
| Neoplasms | 4 |
| Postoperative Pain | 4 |
| Shock, Septic | 4 |
| Stomach Neoplasms | 4 |
| Stroke | 4 |
Trials
Showing 51 to 75 of 223. Each trial links to its page on Pharma Observatory.
123 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.